Clinical trial
Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity…
NCT00041717 · Acorda Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00041717 |
|---|---|
| Title | Safety and Efficacy of Oral Fampridine-SR for the Treatment of Spasticity Resulting From Spinal Cord Injury |
| Official title | Double-Blind, Placebo-Controlled, 12-Week Parallel Group Study to Evaluate Safety and Efficacy of Oral Fampridine-SR in Subjects With Moderate to Severe Spasticity Resulting From Chronic, Incomplete Spinal Cord Injury |
| Lead sponsor | Acorda Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Spinal Cord Injury, Muscle Spasticity |
| Intervention type | Drug, Other |
| Interventions | Fampridine-SR, Placebo |
| Enrollment | 213 |
| Start date | Jul 1, 2002 |
| Primary completion | Feb 1, 2004 |
| Completion | May 1, 2004 |
| First posted | Jul 16, 2002 |
| Last update posted | Jan 14, 2020 |
| Countries | Canada, United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: